CoChat
Sign Up
Cited by 326Alcohol Consumption and Health EffectsLiver Disease Diagnosis and TreatmentLipid metabolism and biosynthesis

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Alcohol effects on hepatic lipid metabolism

Open access
Jeon, Sookyoung, Carr, Rotonya·2020·Journal of Lipid Research
DOI 10.1194/jlr.r119000547PMC PMC7112138
Open this paper in CoChat — free account

Abstract

Alcoholic liver disease (ALD) is the most prevalent type of chronic liver disease with significant morbidity and mortality worldwide. ALD begins with simple hepatic steatosis and progresses to alcoholic steatohepatitis, fibrosis, and cirrhosis. The severity of hepatic steatosis is highly associated with the development of later stages of ALD. This review explores the disturbances of alcohol-induced hepatic lipid metabolism through altered hepatic lipid uptake, de novo lipid synthesis, fatty acid oxidation, hepatic lipid export, and lipid droplet formation and catabolism. In addition, we review emerging data on the contributions of genetics and bioactive lipid metabolism in alcohol-induced hepatic lipid accumulation.

Overview

Integrity signals

Registry

Crossref · 10.1194/jlr.r119000547

Cites

0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 2 references

Research works printed but not linked: 156

  1. Asrani, 2019, Burden of liver diseases in the world, J. Hepatol., 70, 151, 10.1016/j.jhep.2018.09.014 · DOI · Paper page
  2. Edmondson, 1967, The early stage of liver injury in the alcoholic, Medicine (Baltimore)., 46, 119, 10.1097/00005792-196703000-00006 · DOI
  3. Powell, 2005, Steatosis: co-factor in other liver diseases, Hepatology., 42, 5, 10.1002/hep.20750 · DOI
  4. Zakhari, 2006, Overview: how is alcohol metabolized by the body?, Alcohol Res. Health., 29, 245
  5. Carr, 2015, Insulin resistance in clinical and experimental alcoholic liver disease, Ann. N. Y. Acad. Sci., 1353, 1, 10.1111/nyas.12787 · DOI
  6. Zhao, 2015, FGF21 mediates alcohol-induced adipose tissue lipolysis by activation of systemic release of catecholamine in mice, J. Lipid Res., 56, 1481, 10.1194/jlr.M058610 · DOI
  7. Leggio, 2009, Is cortisol involved in the alcohol-related fat mass impairment? A longitudinal clinical study, Alcohol Alcohol., 44, 211, 10.1093/alcalc/agn116 · DOI
  8. Zhong, 2012, Chronic alcohol exposure stimulates adipose tissue lipolysis in mice: role of reverse triglyceride transport in the pathogenesis of alcoholic steatosis, Am. J. Pathol., 180, 998, 10.1016/j.ajpath.2011.11.017 · DOI
  9. Wei, 2013, Chronic alcohol exposure disturbs lipid homeostasis at the adipose tissue-liver axis in mice: analysis of triacylglycerols using high-resolution mass spectrometry in combination with in vivo metabolite deuterium labeling, PLoS One., 8, e55382, 10.1371/journal.pone.0055382 · DOI · Paper page
  10. Carr, 2013, Temporal effects of ethanol consumption on energy homeostasis, hepatic steatosis, and insulin sensitivity in mice, Alcohol. Clin. Exp. Res., 37, 1091, 10.1111/acer.12075 · DOI
  11. Addolorato, 1997, Energy expenditure, substrate oxidation, and body composition in subjects with chronic alcoholism: new findings from metabolic assessment, Alcohol. Clin. Exp. Res., 21, 962
  12. Gandhi, 1984, Alcohol-induced changes in lipids and lipoproteins, Alcohol. Clin. Exp. Res., 8, 29, 10.1111/j.1530-0277.1984.tb05027.x · DOI
  13. Lieber, 1984, Ethanol and lipids, Alcohol. Clin. Exp. Res., 8, 409, 10.1111/j.1530-0277.1984.tb05689.x · DOI
  14. Hussain, 1991, Clearance of chylomicron remnants by the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor, J. Biol. Chem., 266, 13936, 10.1016/S0021-9258(18)92792-4 · DOI
  15. Willnow, 1997, Mechanisms of hepatic chylomicron remnant clearance, Diabet. Med., 14, S75, 10.1002/(SICI)1096-9136(199708)14:3+<S75::AID-DIA449>3.0.CO;2-9 · DOI
  16. Baraona, 1970, Effects of chronic ethanol feeding on serum lipoprotein metabolism in the rat, J. Clin. Invest., 49, 769, 10.1172/JCI106290 · DOI
  17. Donnelly, 2005, Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease, J. Clin. Invest., 115, 1343, 10.1172/JCI23621 · DOI · Paper page
  18. Stahl, 2001, Fatty acid transport proteins: a current view of a growing family, Trends Endocrinol. Metab., 12, 266, 10.1016/S1043-2760(01)00427-1 · DOI
  19. Zhou, 2008, Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis, Gastroenterology., 134, 556, 10.1053/j.gastro.2007.11.037 · DOI
  20. Ronis, 2011, Effects of long-term ethanol administration in a rat total enteral nutrition model of alcoholic liver disease, Am. J. Physiol. Gastrointest. Liver Physiol., 300, G109, 10.1152/ajpgi.00145.2010 · DOI
  21. Clugston, 2014, CD36-deficient mice are resistant to alcohol- and high-carbohydrate-induced hepatic steatosis, J. Lipid Res., 55, 239, 10.1194/jlr.M041863 · DOI
  22. Berk, 2005, Increased hepatocellular uptake of long chain fatty acids occurs by different mechanisms in fatty livers due to obesity or excess ethanol use, contributing to development of steatohepatitis in both settings, Trans. Am. Clin. Climatol. Assoc., 116, 335
  23. Blomstrand, 1973, Studies on the ethanol-induced decrease of fatty acid oxidation in rat and human liver slices, Life Sci., 13, 1131, 10.1016/0024-3205(73)90380-9 · DOI
  24. Cederbaum, 1975, Effect of chronic ethanol ingestion on fatty acid oxidation by hepatic mitochondria, J. Biol. Chem., 250, 5122, 10.1016/S0021-9258(19)41286-6 · DOI
  25. Correnti, 2018, Ethanol and C2 ceramide activate fatty acid oxidation in human hepatoma cells, Sci. Rep., 8, 12923, 10.1038/s41598-018-31025-0 · DOI
  26. Reboucas, 1961, Studies on the pathogenesis of the ethanol-induced fatty liver. I. Synthesis and oxidation of fatty acids by the liver, J. Clin. Invest., 40, 1355, 10.1172/JCI104366 · DOI
  27. Ontko, 1973, Effects of ethanol on the metabolism of free fatty acids in isolated liver cells, J. Lipid Res., 14, 78, 10.1016/S0022-2275(20)39332-9 · DOI
  28. Hoek, 2002, Alcohol and mitochondria: a dysfunctional relationship, Gastroenterology., 122, 2049, 10.1053/gast.2002.33613 · DOI · Paper page
  29. Sonko, 1994, Effect of alcohol on postmeal fat storage, Am. J. Clin. Nutr., 59, 619, 10.1093/ajcn/59.3.619 · DOI
  30. Suter, 1992, The effect of ethanol on fat storage in healthy subjects, N. Engl. J. Med., 326, 983, 10.1056/NEJM199204093261503 · DOI
  31. You, 2004, The role of AMP-activated protein kinase in the action of ethanol in the liver, Gastroenterology., 127, 1798, 10.1053/j.gastro.2004.09.049 · DOI · Paper page
  32. Sachan, 1984, Ameliorating effects of carnitine and its precursors on alcohol-induced fatty liver, Am. J. Clin. Nutr., 39, 738, 10.1093/ajcn/39.5.738 · DOI
  33. Kępka, 2019, Relation of plasma carnitine and aminotransferases to alcohol dose and time of dependence, Alcohol., 81, 62, 10.1016/j.alcohol.2019.04.004 · DOI
  34. Lemasters, 2006, Voltage-dependent anion channel (VDAC) as mitochondrial governator–thinking outside the box, Biochim. Biophys. Acta., 1762, 181, 10.1016/j.bbadis.2005.10.006 · DOI
  35. Holmuhamedov, 2009, Ethanol exposure decreases mitochondrial outer membrane permeability in cultured rat hepatocytes, Arch. Biochem. Biophys., 481, 226, 10.1016/j.abb.2008.10.036 · DOI
  36. Holmuhamedov, 2012, Ethanol suppresses ureagenesis in rat hepatocytes: role of acetaldehyde, J. Biol. Chem., 287, 7692, 10.1074/jbc.M111.293399 · DOI
  37. Mandard, 2004, Peroxisome proliferator-activated receptor α target genes, Cell. Mol. Life Sci., 61, 393, 10.1007/s00018-003-3216-3 · DOI
  38. Fischer, 2003, Peroxisome proliferator-activated receptor α (PPARα) agonist treatment reverses PPARα dysfunction and abnormalities in hepatic lipid metabolism in ethanol-fed mice, J. Biol. Chem., 278, 27997, 10.1074/jbc.M302140200 · DOI
  39. Herzig, 2018, AMPK: guardian of metabolism and mitochondrial homeostasis, Nat. Rev. Mol. Cell Biol., 19, 121, 10.1038/nrm.2017.95 · DOI
  40. Shearn, 2013, Increased dietary fat contributes to dysregulation of the LKB1/AMPK pathway and increased damage in a mouse model of early-stage ethanol-mediated steatosis, J. Nutr. Biochem., 24, 1436, 10.1016/j.jnutbio.2012.12.002 · DOI
  41. Chang, 2014, SIRT1 and other sirtuins in metabolism, Trends Endocrinol. Metab., 25, 138, 10.1016/j.tem.2013.12.001 · DOI
  42. Ruderman, 2010, AMPK and SIRT1: a long-standing partnership?, Am. J. Physiol. Endocrinol. Metab., 298, E751, 10.1152/ajpendo.00745.2009 · DOI · Paper page
  43. You, 2008, Involvement of mammalian sirtuin 1 in the action of ethanol in the liver, Am. J. Physiol. Gastrointest. Liver Physiol., 294, G892, 10.1152/ajpgi.00575.2007 · DOI
  44. Ajmo, 2008, Resveratrol alleviates alcoholic fatty liver in mice, Am. J. Physiol. Gastrointest. Liver Physiol., 295, G833, 10.1152/ajpgi.90358.2008 · DOI · Paper page
  45. Sanders, 2016, De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose, Biol. Rev. Camb. Philos. Soc., 91, 452, 10.1111/brv.12178 · DOI
  46. Zhou, 2014, Disturbances in the murine hepatic circadian clock in alcohol-induced hepatic steatosis, Sci. Rep., 4, 3725, 10.1038/srep03725 · DOI
  47. Yen, 2008, DGAT enzymes and triacylglycerol biosynthesis, J. Lipid Res., 49, 2283, 10.1194/jlr.R800018-JLR200 · DOI · Paper page
  48. Foufelle, 2002, New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c, Biochem. J., 366, 377, 10.1042/bj20020430 · DOI
  49. Ji, 2006, Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model, J. Hepatol., 45, 717, 10.1016/j.jhep.2006.05.009 · DOI
  50. Yin, 2007, Differential gene expression and lipid metabolism in fatty liver induced by acute ethanol treatment in mice, Toxicol. Appl. Pharmacol., 223, 225, 10.1016/j.taap.2007.06.018 · DOI
  51. You, 2002, Ethanol induces fatty acid synthesis pathways by activation of sterol regulatory element-binding protein (SREBP), J. Biol. Chem., 277, 29342, 10.1074/jbc.M202411200 · DOI
  52. Esfandiari, 2010, Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol-fed cystathionine beta synthase-deficient mouse, Hepatology., 51, 932, 10.1002/hep.23382 · DOI
  53. Dara, 2011, The contribution of endoplasmic reticulum stress to liver diseases, Hepatology., 53, 1752, 10.1002/hep.24279 · DOI
  54. Peng, 2009, Adenosine signaling contributes to ethanol-induced fatty liver in mice, J. Clin. Invest., 119, 582, 10.1172/JCI37409 · DOI
  55. Jeong, 2008, Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver, Cell Metab., 7, 227, 10.1016/j.cmet.2007.12.007 · DOI
  56. Bode, 1987, Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess, J. Hepatol., 4, 8, 10.1016/S0168-8278(87)80003-X · DOI
  57. Endo, 2007, TNF-α induces hepatic steatosis in mice by enhancing gene expression of sterol regulatory element binding protein-1c (SREBP-1c), Exp. Biol. Med. (Maywood)., 232, 614
  58. Horiguchi, 2008, Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury, Gastroenterology., 134, 1148, 10.1053/j.gastro.2008.01.016 · DOI
  59. Liangpunsakul, 2013, Activation of carbohydrate response element-binding protein by ethanol, J. Investig. Med., 61, 270, 10.2310/JIM.0b013e31827c2795 · DOI
  60. Marmier, 2015, Novel role for carbohydrate responsive element binding protein in the control of ethanol metabolism and susceptibility to binge drinking, Hepatology., 62, 1086, 10.1002/hep.27778 · DOI
  61. Gavrilova, 2003, Liver peroxisome proliferator-activated receptor γ contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass, J. Biol. Chem., 278, 34268, 10.1074/jbc.M300043200 · DOI · Paper page
  62. Zhang, 2016, Hepatic peroxisome proliferator-activated receptor gamma signaling contributes to alcohol-induced hepatic steatosis and inflammation in mice, Alcohol. Clin. Exp. Res., 40, 988, 10.1111/acer.13049 · DOI
  63. Enomoto, 2003, Prevention of ethanol-induced liver injury in rats by an agonist of peroxisome proliferator-activated receptor-γ, pioglitazone, J. Pharmacol. Exp. Ther., 306, 846, 10.1124/jpet.102.047217 · DOI
  64. Tomita, 2004, Pioglitazone prevents alcohol-induced fatty liver in rats through up-regulation of c-Met, Gastroenterology., 126, 873, 10.1053/j.gastro.2003.12.008 · DOI · Paper page
  65. Bou Khalil, 2010, Lipin - the bridge between hepatic glycerolipid biosynthesis and lipoprotein metabolism, Biochim. Biophys. Acta., 1801, 1249, 10.1016/j.bbalip.2010.07.008 · DOI
  66. Hu, 2012, Regulation of hepatic lipin-1 by ethanol: role of AMP-activated protein kinase/sterol regulatory element-binding protein 1 signaling in mice, Hepatology., 55, 437, 10.1002/hep.24708 · DOI
  67. Hu, 2013, Hepatic-specific lipin-1 deficiency exacerbates experimental alcohol-induced steatohepatitis in mice, Hepatology., 58, 1953, 10.1002/hep.26589 · DOI
  68. Yin, 2012, MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1, J. Biol. Chem., 287, 9817, 10.1074/jbc.M111.333534 · DOI
  69. Yin, 2014, Deletion of SIRT1 from hepatocytes in mice disrupts lipin-1 signaling and aggravates alcoholic fatty liver, Gastroenterology., 146, 801, 10.1053/j.gastro.2013.11.008 · DOI
  70. Shen, 2010, Involvement of adiponectin-SIRT1-AMPK signaling in the protective action of rosiglitazone against alcoholic fatty liver in mice, Am. J. Physiol. Gastrointest. Liver Physiol., 298, G364, 10.1152/ajpgi.00456.2009 · DOI
  71. Everitt, 2013, Ethanol administration exacerbates the abnormalities in hepatic lipid oxidation in genetically obese mice, Am. J. Physiol. Gastrointest. Liver Physiol., 304, G38, 10.1152/ajpgi.00309.2012 · DOI
  72. Wurie, 2012, Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells, FEBS J., 279, 3033, 10.1111/j.1742-4658.2012.08684.x · DOI
  73. Qi, 2012, The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of DGAT1 and -2, J. Lipid Res., 53, 1106, 10.1194/jlr.M020156 · DOI
  74. Wada, 2008, Fish oil fed prior to ethanol administration prevents acute ethanol-induced fatty liver in mice, J. Hepatol., 49, 441, 10.1016/j.jhep.2008.04.026 · DOI
  75. Wang, 2010, Involvement and mechanism of DGAT2 upregulation in the pathogenesis of alcoholic fatty liver disease, J. Lipid Res., 51, 3158, 10.1194/jlr.M007948 · DOI
  76. Sugimoto, 2002, Decreased microsomal triglyceride transfer protein activity contributes to initiation of alcoholic liver steatosis in rats, J. Hepatol., 36, 157, 10.1016/S0168-8278(01)00263-X · DOI
  77. Nanji, 2004, Alcoholic liver injury in the rat is associated with reduced expression of peroxisome proliferator-α (PPARα)-regulated genes and is ameliorated by PPARα activation, J. Pharmacol. Exp. Ther., 310, 417, 10.1124/jpet.103.064717 · DOI
  78. Améen, 2005, Activation of peroxisome proliferator-activated receptor α increases the expression and activity of microsomal triglyceride transfer protein in the liver, J. Biol. Chem., 280, 1224, 10.1074/jbc.M412107200 · DOI
  79. Noga, 2002, An unexpected requirement for phosphatidylethanolaminen-methyltransferase in the secretion of very low density lipoproteins, J. Biol. Chem., 277, 42358, 10.1074/jbc.M204542200 · DOI
  80. Vance, 2005, Metabolic insights into phospholipid function using gene-targeted mice, J. Biol. Chem., 280, 10877, 10.1074/jbc.R400038200 · DOI
  81. Kharbanda, 2007, Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway, J. Hepatol., 46, 314, 10.1016/j.jhep.2006.08.024 · DOI
  82. Carr, 2016, Pathophysiology of lipid droplet proteins in liver diseases, Exp. Cell Res., 340, 187, 10.1016/j.yexcr.2015.10.021 · DOI
  83. Li, 2013, Preservation of hepatocyte nuclear factor-4alpha contributes to the beneficial effect of dietary medium chain triglyceride on alcohol-induced hepatic lipid dyshomeostasis in rats, Alcohol. Clin. Exp. Res., 37, 587, 10.1111/acer.12013 · DOI
  84. Walther, 2009, The life of lipid droplets, Biochim. Biophys. Acta., 1791, 459, 10.1016/j.bbalip.2008.10.009 · DOI
  85. Kilwein, 2019, Lipid droplet motility and organelle contacts, Contact (Thousand Oaks)., 2
  86. Gluchowski, 2017, Lipid droplets and liver disease: from basic biology to clinical implications, Nat. Rev. Gastroenterol. Hepatol., 14, 343, 10.1038/nrgastro.2017.32 · DOI
  87. Zhou, 2012, Cidea promotes hepatic steatosis by sensing dietary fatty acids, Hepatology., 56, 95, 10.1002/hep.25611 · DOI
  88. Bickel, 2009, PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores, Biochim. Biophys. Acta., 1791, 419, 10.1016/j.bbalip.2009.04.002 · DOI
  89. Dalen, 2004, Adipose tissue expression of the lipid droplet–associating proteins S3-12 and perilipin is controlled by peroxisome proliferator-activated receptor-γ, Diabetes., 53, 1243, 10.2337/diabetes.53.5.1243 · DOI
  90. Brasaemle, 1997, Adipose differentiation-related protein is an ubiquitously expressed lipid storage droplet-associated protein, J. Lipid Res., 38, 2249, 10.1016/S0022-2275(20)34939-7 · DOI
  91. Wolins, 2006, OXPAT/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization, Diabetes., 55, 3418, 10.2337/db06-0399 · DOI
  92. Straub, 2008, Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis, Hepatology., 47, 1936, 10.1002/hep.22268 · DOI
  93. Carr, 2017, Perilipin staining distinguishes between steatosis and nonalcoholic steatohepatitis in adults and children, Clin. Gastroenterol. Hepatol., 15, 145, 10.1016/j.cgh.2016.08.023 · DOI
  94. Motomura, 2006, Up-regulation of ADRP in fatty liver in human and liver steatosis in mice fed with high fat diet, Biochem. Biophys. Res. Commun., 340, 1111, 10.1016/j.bbrc.2005.12.121 · DOI
  95. Granneman, 2011, Interactions of perilipin-5 (plin5) with adipose triglyceride lipase, J. Biol. Chem., 286, 5126, 10.1074/jbc.M110.180711 · DOI
  96. Mak, 2008, Adipose differentiation-related protein is a reliable lipid droplet marker in alcoholic fatty liver of rats, Alcohol. Clin. Exp. Res., 32, 683, 10.1111/j.1530-0277.2008.00624.x · DOI
  97. Carr, 2014, Absence of perilipin 2 prevents hepatic steatosis, glucose intolerance and ceramide accumulation in alcohol-fed mice, PLoS One., 9, e97118, 10.1371/journal.pone.0097118 · DOI
  98. Raynard, 2002, Risk factors of fibrosis in alcohol-induced liver disease, Hepatology., 35, 635, 10.1053/jhep.2002.31782 · DOI
  99. Bulankina, 2009, TIP47 functions in the biogenesis of lipid droplets, J. Cell Biol., 185, 641, 10.1083/jcb.200812042 · DOI
  100. Carr, 2012, Reduction of TIP47 improves hepatic steatosis and glucose homeostasis in mice, Am. J. Physiol. Regul. Integr. Comp. Physiol., 302, R996, 10.1152/ajpregu.00177.2011 · DOI
  101. Gu, 2019, Plin3 protects against alcoholic liver injury by facilitating lipid export from the endoplasmic reticulum, J. Cell. Biochem., 120, 16075, 10.1002/jcb.28889 · DOI
  102. Jambunathan, 2011, FSP27 promotes lipid droplet clustering and then fusion to regulate triglyceride accumulation, PLoS One., 6, e28614, 10.1371/journal.pone.0028614 · DOI
  103. Xu, 2015, Fat-specific protein 27/CIDEC promotes development of alcoholic steatohepatitis in mice and humans, Gastroenterology., 149, 1030, 10.1053/j.gastro.2015.06.009 · DOI
  104. Tian, 2010, Variant in PNPLA3 is associated with alcoholic liver disease, Nat. Genet., 42, 21, 10.1038/ng.488 · DOI
  105. Stickel, 2011, Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in Caucasians, Hepatology., 53, 86, 10.1002/hep.24017 · DOI
  106. Stickel, 2017, The genetics of alcohol dependence and alcohol-related liver disease, J. Hepatol., 66, 195, 10.1016/j.jhep.2016.08.011 · DOI
  107. Basantani, 2011, Pnpla3/adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome, J. Lipid Res., 52, 318, 10.1194/jlr.M011205 · DOI
  108. Chen, 2010, Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease, Hepatology., 52, 1134, 10.1002/hep.23812 · DOI
  109. Li, 2012, Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis, J. Clin. Invest., 122, 4130, 10.1172/JCI65179 · DOI
  110. BasuRay, 2019, Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis, Proc. Natl. Acad. Sci. USA., 116, 9521, 10.1073/pnas.1901974116 · DOI
  111. Negoita, 2019, PNPLA3 variant M148 causes resistance to starvation-mediated lipid droplet autophagy in human hepatocytes, J. Cell. Biochem., 120, 343, 10.1002/jcb.27378 · DOI
  112. Teo, 2020, rs641738C>T near MBOAT7 promotes steatosis, NASH, fibrosis and hepatocellular carcinoma in non-alcoholic fatty liver disease: a meta-analysis, medRxiv.
  113. Caddeo, 2019, MBOAT7 is anchored to endomembranes by six transmembrane domains, J. Struct. Biol., 206, 349, 10.1016/j.jsb.2019.04.006 · DOI
  114. Yamashita, 2003, Reverse reaction of lysophosphatidylinositol acyltransferase functional reconstitution of coenzyme A-dependent transacylation system, J. Biol. Chem., 278, 30382, 10.1074/jbc.M303391200 · DOI
  115. Magné, 2013, The minor allele of the missense polymorphism Ser251Pro in perilipin 2 (PLIN2) disrupts an α-helix, affects lipolysis, and is associated with reduced plasma triglyceride concentration in humans, FASEB J., 27, 3090, 10.1096/fj.13-228759 · DOI
  116. Lin, 2013, Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice, J. Hepatol., 58, 993, 10.1016/j.jhep.2013.01.011 · DOI
  117. Ding, 2010, Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice, Gastroenterology., 139, 1740, 10.1053/j.gastro.2010.07.041 · DOI · Paper page
  118. Ni, 2013, Critical role of FoxO3a in alcohol-induced autophagy and hepatotoxicity, Am. J. Pathol., 183, 1815, 10.1016/j.ajpath.2013.08.011 · DOI
  119. Thomes, 2015, Acute and chronic ethanol administration differentially modulate hepatic autophagy and transcription factor EB, Alcohol. Clin. Exp. Res., 39, 2354, 10.1111/acer.12904 · DOI
  120. Rasineni, 2017, Ethanol-induced steatosis involves impairment of lipophagy, associated with reduced Dynamin2 activity, Hepatol. Commun., 1, 501, 10.1002/hep4.1063 · DOI
  121. Schulze, 2017, Ethanol exposure inhibits hepatocyte lipophagy by inactivating the small guanosine triphosphatase Rab7, Hepatol. Commun., 1, 140, 10.1002/hep4.1021 · DOI
  122. Clugston, 2017, The hepatic lipidome: a gateway to understanding the pathogenes is of alcohol-induced fatty liver, Curr. Mol. Pharmacol., 10, 195, 10.2174/1874467208666150817111419 · DOI
  123. Clugston, 2011, Altered hepatic lipid metabolism in C57BL/6 mice fed alcohol: a targeted lipidomic and gene expression study, J. Lipid Res., 52, 2021, 10.1194/jlr.M017368 · DOI
  124. Fernando, 2010, 1H and 31P NMR lipidome of ethanol-induced fatty liver, Alcohol. Clin. Exp. Res., 34, 1937, 10.1111/j.1530-0277.2010.01283.x · DOI
  125. Fernando, 2011, Lipidomic changes in rat liver after long-term exposure to ethanol, Toxicol. Appl. Pharmacol., 255, 127, 10.1016/j.taap.2011.05.022 · DOI
  126. Bosner, 1988, Receptor-like function of heparin in the binding and uptake of neutral lipids, Proc. Natl. Acad. Sci. USA., 85, 7438, 10.1073/pnas.85.20.7438 · DOI
  127. Athenstaedt, 2006, The life cycle of neutral lipids: synthesis, storage and degradation, Cell. Mol. Life Sci., 63, 1355, 10.1007/s00018-006-6016-8 · DOI
  128. Shimizu, 2009, Lipid mediators in health and disease: enzymes and receptors as therapeutic targets for the regulation of immunity and inflammation, Annu. Rev. Pharmacol. Toxicol., 49, 123, 10.1146/annurev.pharmtox.011008.145616 · DOI
  129. Bradford, 2008, Metabolomic profiling of a modified alcohol liquid diet model for liver injury in the mouse uncovers new markers of disease, Toxicol. Appl. Pharmacol., 232, 236, 10.1016/j.taap.2008.06.022 · DOI
  130. Loftus, 2011, Metabonomic investigation of liver profiles of nonpolar metabolites obtained from alcohol-dosed rats and mice using high mass accuracy MSn analysis, J. Proteome Res., 10, 705, 10.1021/pr100885w · DOI
  131. Zhao, 2011, Ethanol-induced alterations in fatty acid-related lipids in serum and tissues in mice, Alcohol. Clin. Exp. Res., 35, 229, 10.1111/j.1530-0277.2010.01338.x · DOI
  132. Jang, 2012, Metabolic profiling of an alcoholic fatty liver in zebrafish (Danio rerio), Mol. Biosyst., 8, 2001, 10.1039/c2mb25073j · DOI
  133. Fernando, 2012, Hepatic lipid profiling of deer mice fed ethanol using (1)H and (3)(1)P NMR spectroscopy: a dose-dependent subchronic study, Toxicol. Appl. Pharmacol., 264, 361, 10.1016/j.taap.2012.07.026 · DOI
  134. Nanji, 1995, Dietary saturated fatty acids: a novel treatment for alcoholic liver disease, Gastroenterology., 109, 547, 10.1016/0016-5085(95)90344-5 · DOI
  135. You, 2005, Role of adiponectin in the protective action of dietary saturated fat against alcoholic fatty liver in mice, Hepatology., 42, 568, 10.1002/hep.20821 · DOI
  136. Chen, 2015, Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice, Gastroenterology., 148, 203, 10.1053/j.gastro.2014.09.014 · DOI · Paper page
  137. Ramirez, 2013, Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis, Alcohol Alcohol., 48, 39, 10.1093/alcalc/ags106 · DOI
  138. Longato, 2012, Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease, Oxid. Med. Cell. Longev., 2012, 479348, 10.1155/2012/479348 · DOI
  139. Chavez, 2012, A ceramide-centric view of insulin resistance, Cell Metab., 15, 585, 10.1016/j.cmet.2012.04.002 · DOI
  140. Liangpunsakul, 2010, Inhibitory effect of ethanol on AMPK phosphorylation is mediated in part through elevated ceramide levels, Am. J. Physiol. Gastrointest. Liver Physiol., 298, G1004, 10.1152/ajpgi.00482.2009 · DOI
  141. Hannun, 2011, Many ceramides, J. Biol. Chem., 286, 27855, 10.1074/jbc.R111.254359 · DOI
  142. Williams, 2018, A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis, FASEB J., 32, 130, 10.1096/fj.201601142R · DOI
  143. Tong, 2014, Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin, Int. J. Exp. Pathol., 95, 49, 10.1111/iep.12052 · DOI
  144. Deaciuc, 2000, Apoptosis and dysregulated ceramide metabolism in a murine model of alcohol-enhanced lipopolysaccharide hepatotoxicity, Alcohol. Clin. Exp. Res., 24, 1557, 10.1111/j.1530-0277.2000.tb04575.x · DOI
  145. Liangpunsakul, 2012, Imipramine blocks ethanol-induced ASMase activation, ceramide generation, and PP2A activation, and ameliorates hepatic steatosis in ethanol-fed mice, Am. J. Physiol. Gastrointest. Liver Physiol., 302, G515, 10.1152/ajpgi.00455.2011 · DOI
  146. Fernandez, 2013, ASMase is required for chronic alcohol induced hepatic endoplasmic reticulum stress and mitochondrial cholesterol loading, J. Hepatol., 59, 805, 10.1016/j.jhep.2013.05.023 · DOI
  147. Schlemmer, 2005, Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled 31P magnetic resonance spectroscopy, J. Hepatol., 42, 752, 10.1016/j.jhep.2004.12.032 · DOI
  148. Vance, 1988, The methylation of phosphatidylethanolamine, Prog. Lipid Res., 27, 61, 10.1016/0163-7827(88)90005-7 · DOI
  149. Cui, 1996, Expression of phosphatidylethanolamine n-methyltransferase-2 is markedly enhanced in long term choline-deficient rats, J. Biol. Chem., 271, 2839, 10.1074/jbc.271.5.2839 · DOI
  150. Barak, 1973, Relationship of ethanol to choline metabolism in the liver: a review, Am. J. Clin. Nutr., 26, 1234, 10.1093/ajcn/26.11.1234 · DOI
  151. Duce, 1988, S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis, Hepatology., 8, 65, 10.1002/hep.1840080113 · DOI
  152. Lieber, 1994, Hepatic phosphatidylethanolamine methyltransferase activity is decreased by ethanol and increased by phosphatidylcholine, Alcohol. Clin. Exp. Res., 18, 592, 10.1111/j.1530-0277.1994.tb00915.x · DOI
  153. Lu, 2000, Changes in methionine adenosyltransferase and S-adenosylmethionine homeostasis in alcoholic rat liver, Am. J. Physiol. Gastrointest. Liver Physiol., 279, G178, 10.1152/ajpgi.2000.279.1.G178 · DOI
  154. Lieber, 1994, Phosphatidylcholine protects against fibrosis and cirrhosis in the baboon, Gastroenterology., 106, 152, 10.1016/S0016-5085(94)95023-7 · DOI
  155. Lieber, 2003, II. Veterans Affairs Cooperative Study of polyenylphosphatidylcholine in alcoholic liver disease, Alcohol. Clin. Exp. Res., 27, 1765, 10.1097/01.ALC.0000093743.03049.80 · DOI
  156. Li, 2006, The ratio of phosphatidylcholine to phosphatidylethanolamine influences membrane integrity and steatohepatitis, Cell Metab., 3, 321, 10.1016/j.cmet.2006.03.007 · DOI

Cited by

Sorted by citations

Items 201–253 of 253

Metadata

Authors
Jeon, S., & Carr, R.
Affiliations
University of Pennsylvania (US)
Corresponding author
Carr, Rotonya
ORCID
Venue
Journal of Lipid Research
Publisher
Elsevier BV
Published
2020-04
Volume
61
Issue
4
Pages
470-479
ISSN
0022-2275 (ISSN-L)
DOI
10.1194/jlr.r119000547
PMC
PMC7112138
OpenAlex
W3005408539
Cited by
326
References
161
Citations by year
2026: 58 · 2025: 78 · 2024: 76 · 2023: 49 · 2022: 45 · 2021: 13 · 2020: 7
FWCI
4.37
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Lipid Research (publishedVersion, cc-by)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institutes of Health (R01 AA026302-02, P30 DK0503060)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
Keywords
alcoholic liver disease, hepatic lipid metabolism, hepatic steatosis, alcoholic steatohepatitis, fatty acid oxidation, de novo lipogenesis, lipid export, lipid droplet formation, genetic susceptibility, bioactive lipids, liver fibrosis
MeSH terms
Ethanol, Animals, Humans, Liver, Lipogenesis, Lipid Metabolism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review